Current trials on angiotensin-converting enzyme inhibitors and endothelial dysfunction.
Several mechanisms are thought to play a role in the improvement in endothelial vasodilation produced by angiotensin-converting enzyme inhibitors. Both animal and clinical data are reviewed.